Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
M2M with Ravi Ananthanarayanan
Description
Ranbaxy Laboratories should have seen its shares soar with its launch of a generic version of the drug Lipitor in the US. So why are investors not enthused?
More from User
06:52
Jet Airways crisis: Who is to blame, lending banks or promoter Naresh Goyal?
Mint
01:38
What to expect from Reliance Q4 earnings?
Mint
29:58
Zia Mody on adversarial deal making, fear of missing out in private equity
Mint
19:20
Apex Court squashes RBI's Feb 12 Circular on Stressed Assets Resolution : A Decode
Mint
12:50
Marico Founder Harsh Mariwala on how Indian start-ups can scale up & thrive
Mint
23:10
'Hostile' takeovers: L&T-Mindtree saga signals new era in Indian M&A deals?
Mint
Related Videos
01:38
M2M with Mobis Philipose
Mint
01:24
M2M on IT Services Sector
Mint
01:09
M2M on State Electricity Boards
Mint
00:35
BJP's Ravi Shankar Prasad on forming a stable government
Mint
02:35
Artists At Work | Ravi Subramanian
Mint
02:08
Interview: Ravi Venkatesh, Director, Infosys
Mint